Hemoglobin A1c (HbA1c) is widely used as an index of mean glycemia, a measure of risk for the development of diabetes complications, and a measure of the quality of diabetes care. Emerging literature suggests that, although HbA1c levels change little over time within persons without diabetes, they vary considerably among individuals, suggesting that factors other than glycemia may impact HbA1c. Racial and ethnic differences in HbA1c have been described that do not appear to be explained by differences in glycemia. It is imperative that the nonglycemic factors that affect HbAlc be more clearly defined. Even more important, it must be determined whether differences among individuals or groups correlate with susceptibility to complications or merely reflect variation in hemoglobin glycation.
AllenDWSchroederWABalogJ. Observations on the chromatographic heterogeneity of normal adult and fetal human hemoglobin: a study of the effects of crystallization and chromatography on the heterogeneity and isoleucine content. J Am Chem Soc.1958;80 (7): 1628–34.
2.
RajbarS. An abnormal hemoglobin in red cells of diabetics. Clin Chem Acta.1968;22 (2): 296–8.
3.
KoenigRJPetersonCMKiloCCeramiAWilliamsonJR. Hemoglobin A1c as an indicator of the degree of glucose intolerance in diabetes. Diabetes.1976;25 (3): 230–2.
4.
KoenigRJPetersonCMJonesRLSaudekCLehrmanMCeramiA. Correlation of glucose regulation and hemoglobin A1c in diabetes mellitus. N Engl J Med.1976;295 (8): 417–20.
GoldsteinDELittleRRLorenzRAMaloneJINathanDPetersonCM. Tests of glycemia in diabetes. Diabetes Care.1995;18 (6): 896–909.
7.
National Glycohemoglobin Standardization Program. Factors that interfere with GHB (HbA1c) test results. Updated 4/08. http://www.ngsp.org/prog/factors.htm.
8.
CookJDFinchCASmithNJ. Evaluation of the iron status of a population. Blood.1976;48 (3): 449–55.
9.
CobanEOzdoganMTimuragaogluA. Effect of iron deficiency anemia on the levels of hemoglobin A1c in nondiabetic patients. Acta Haematol.2004;112 (3): 126–8.
10.
NathanDMKuenenJBorgRZhengHSchoenfeldDHeineRJ, A1c-Derived Average Glucose Study Group. Translating the A1C assay into estimated average glucose values. Diabetes Care.2008;31 (8): 1473–8.
11.
YudkinJSForrestRDJacksonCARyleAJDavieSGouldBJ. Unexplained variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia. Diabetologia.1990;33 (4): 208–15.
12.
The DCCT Research Group. Diabetes Control and Complications Trial (DCCT): results of a feasibility study. Diabetes Care.1987;10 (1): 1–19.
13.
MeigsJBNathanDMCupplesLAWilsonPWSingerDE. Tracking of glycated hemoglobin in the original cohort of the Framingham Heart Study. J Clin Epidemiol.1996;49 (4): 411–7.
14.
StricklandMHPatonRCWalesJK. Hemoglobin A1c concentrations in men and women with diabetes. Br Med J.1984;289: 733.
15.
KalishGMBarrett-ConnorELaughlinGAGulanskiBI. Postmenopausal Estrogen/Progestin Intervention Trial. Association of endogenous sex hormones and insulin resistance among postmenopausal women: results from the Postmenopausal Estrogen/Progestin Intervention Trial. J Clin Endocrinol Metab.2003;88 (4): 1646–52.
16.
AranetaMRBarrett-ConnorE. Ethnic differences in visceral adipose tissue and type 2 diabetes: Filipino, African-American, and white women. Obes Res.2005;13 (8): 1458–65.
17.
SniederHSawtellPARossLWalkerJSpectorTDLeslieRD. HbA(1c) levels are genetically determined even in type 1 diabetes: evidence from healthy and diabetic twins. Diabetes.2001;50 (12): 2858–63.
18.
CohenRMSniederHLindsellCJBeyanHHawaMIBlinkoSEdwardsRSpectorTDLeslieRD. Evidence for independent heritability of the glycation gap (glycosylation gap) fraction of HbA1c in nondiabetic twins. Diabetes Care.2006;29 (8): 1739–43.
19.
SaaddineJBFagot-CampagnaARolkaDNarayanKMGeissLEberhardtMFlegalKM. Distribution of HbA(1c) levels for children and young adults in the U.S.: Third National Health and Nutrition Examination Study. Diabetes Care.2002;25 (8): 1326–30.
20.
EberhardtMSLacklandDTWheelerFCGermanRRTeutschSM. Is race related to glycemic control? An assessment of glycosylated hemoglobin in two South Carolina communities. J Clin Epidemiol.1994;47 (10): 1181–9.
21.
KirkJKBellRABertoniAGArcuryTAQuandtSAGoffDCJrNarayanKM. Ethnic disparities: control of glycemia, blood pressure, and LDL cholesterol among US adults with type 2 diabetes. Ann Pharmacother.2005;39 (9): 1489–501.
22.
SummersonJHKonenJCDignanMB. Race-related differences in metabolic control among adults with diabetes. South Med J.1992;85 (10): 953–6.
23.
WisdomKFryzekJPHavstadSLAndersonRMDreilingMCTilleyBC. Comparison of laboratory test frequency and test results between African-Americans and Caucasians with diabetes: opportunity for improvement. Findings from a large urban health maintenance organization. Diabetes Care.1997;20 (6): 971–7.
24.
GaryTLMcGuireMMcCauleyJBrancatiFL. Racial comparisons of health care and glycemic control for African American and white diabetic adults in an urban managed care organization. Dis Manag.2004;7 (1): 25–34.
25.
BrownAFGerzoffRBKarterAJGreggESaffordMWaitzfelderBBecklesGLBrusuelasRMangioneCM, the TRIAD Study Group. Health behaviors and quality of care among Latinos with diabetes in managed care. Am J Public Health.2003;93 (10): 1694–8.
26.
BrownAFGreggEWStevensMRKarterAJWeinbergerMSaffordMMGaryTLCaputoDAWaitzfelderBKimCBecklesGL. Race, ethnicity, socioeconomic position, and quality of care for adults with diabetes enrolled in manage care: the Translating Research Into Action for Diabetes (TRIAD) Study. Diabetes Care.2005;28 (12): 2864–70.
27.
HeislerMFaulJDHaywardRALangaKMBlaumCWeirD. Mechanisms for racial and ethnic disparities in glycemic control in middle-aged and older Americans in the Health and Retirement Study. Arch Intern Med.2007;167 (17): 1853–60.
28.
AdamsASTrinactyCMZhangFKleinmanKGrantRWMeigsJBSoumeraiSBRoss-DegnanD. Medication adherence and racial differences in A1C control. Diabetes Care.2008;31 (5): 916–21.
29.
HermanWHMaYUwaifoGHaffnerSKahnSEHortonESLachinJMMontezMGBrennemanTBarrett-ConnorE, Diabetes Prevention Program Research Group. Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care.2007;30 (10): 2453–7.
30.
VibertiGLachinJHolmanRZinmanBHaffnerSKravitzBHeiseMAJonesNPO'NeillMCFreedMIKahnSEHermanWH, ADOPT Study Group. A Diabetes Outcome Progression Trial (ADOPT): baseline characteristics of type 2 diabetic patients in North America and Europe. Diabet Med.2006;23 (12): 1289–94.
31.
HermanWHDunganKMWolffenbuttelBHBuseJBFahrbachJLJiangHMartinS. Racial and ethnic differences in mean plasma glucose, hemoglobin A1c, and 1,5-anhydroglucitol in over 2000 patients with type 2 diabetes. J Clin Endocrinol Metab.2009;94 (5): 1689–94.
32.
Diabetes Research in Children Netword (DirecNet) Study Group, Wilson DM, Kollman. Relationship of A1C to glucose concentrations in children with type 1 diabetes: assessments by high-frequency glucose determinations by sensors. Diabetes Care.2008;31 (3): 381–5.
33.
GouldBJDavieSJYudkinJS. Investigation of the mechanism underlying the variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia. Clin Chim Acta.1997;260 (1): 49–64.
34.
DelpierreGCollardFFortpiedJVan SchaftingenE. Fructosamine 3-kinase is involved in an intracellular deglycation pathway in human erythrocytes. Biochem J.2002;365 (Pt 3): 801–8.
35.
SaudekCDHermanWHSacksDBBergenstalRMEdelmanDDavidsonMB. A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab.2008;93 (7): 2447–53.
